Search research articles
Contact Us
Filters
Showing results (261-270 of 939) with videos related to
Page
of 94
Sort By:
Plos One
|
May 14, 2013
Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway
Dorothee Gramatzki, Caroline Herrmann, Caroline Happold, et al.
Brain and Behavior
|
April 18, 2017
Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients
Nina Feddermann-Demont, Astrid Junge, Konrad P Weber, et al.
Journal of Neurology
|
March 8, 2014
Etoposide/carboplatin chemotherapy for the treatment of metastatic myxomatous cerebral aneurysms
Meret Branscheidt, Karl Frontzek, Oliver Bozinov, et al.
Neuro-Oncology
|
February 18, 2009
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro
Gabriele D Maurer, Isabel Tritschler, Barbara Adams, et al.
Multiple Sclerosis and Related Disorders
|
December 19, 2025
Relapse activity during pregnancy and the postpartum year is associated with accelerated disability progression in multiple sclerosis
Lea I Walter, Veronika Kana, Sarah Hösli, et al.
Neuro-Oncology Practice
|
October 13, 2025
Intra-Ommaya reservoir administration technique affects cerebrospinal fluid drug distribution in patients with leptomeningeal metastases
Kyle Tuohy, Alireza Mansouri, Mark Tulchinsky, et al.
Mabs
|
November 2, 2020
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors <i>in vivo</i>
Lisa Nadal, Riccardo Corbellari, Alessandra Villa, et al.
Future Oncology (London, England)
|
March 23, 2011
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies
David A Reardon, Bart Neyns, Michael Weller, et al.
Antioxidants & Redox Signaling
|
June 20, 2007
Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy
Georgios Grammatikos, Volker Teichgräber, Alexander Carpinteiro, et al.
Journal of Neuro-Oncology
|
November 7, 2008
ACNU-based chemotherapy for recurrent glioma in the temozolomide era
Caroline Happold, Patrick Roth, Wolfgang Wick, et al.
Page
of 94
Search research articles
Search
Showing results (261-270 of 939) with videos related to
Sort By:
Page
of 94
Plos One
|
May 14, 2013
Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway
Dorothee Gramatzki, Caroline Herrmann, Caroline Happold, et al.
Brain and Behavior
|
April 18, 2017
Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients
Nina Feddermann-Demont, Astrid Junge, Konrad P Weber, et al.
Journal of Neurology
|
March 8, 2014
Etoposide/carboplatin chemotherapy for the treatment of metastatic myxomatous cerebral aneurysms
Meret Branscheidt, Karl Frontzek, Oliver Bozinov, et al.
Neuro-Oncology
|
February 18, 2009
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro
Gabriele D Maurer, Isabel Tritschler, Barbara Adams, et al.
Multiple Sclerosis and Related Disorders
|
December 19, 2025
Relapse activity during pregnancy and the postpartum year is associated with accelerated disability progression in multiple sclerosis
Lea I Walter, Veronika Kana, Sarah Hösli, et al.
Neuro-Oncology Practice
|
October 13, 2025
Intra-Ommaya reservoir administration technique affects cerebrospinal fluid drug distribution in patients with leptomeningeal metastases
Kyle Tuohy, Alireza Mansouri, Mark Tulchinsky, et al.
Mabs
|
November 2, 2020
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors <i>in vivo</i>
Lisa Nadal, Riccardo Corbellari, Alessandra Villa, et al.
Future Oncology (London, England)
|
March 23, 2011
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies
David A Reardon, Bart Neyns, Michael Weller, et al.
Antioxidants & Redox Signaling
|
June 20, 2007
Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy
Georgios Grammatikos, Volker Teichgräber, Alexander Carpinteiro, et al.
Journal of Neuro-Oncology
|
November 7, 2008
ACNU-based chemotherapy for recurrent glioma in the temozolomide era
Caroline Happold, Patrick Roth, Wolfgang Wick, et al.
Page
of 94